Tetris Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
- Paid Up Capital ₹ 3.01 M
- Company Age 24 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 4134.52%
- Profit Growth 75.00%
- Ebitda 38.35%
- Net Worth -4.96%
- Total Assets 24.71%
About Tetris Biotech
Tetris Biotech Limited (TBL) is a Public Limited Indian Non-Government Company incorporated in India on 21 July 2000 and has a history of 24 years and seven months. Its registered office is in Delhi, India.
The Company is engaged in the Home & Lifestyle Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.01 M, as per Ministry of Corporate Affairs (MCA) records.
Subhajit Sinha, Jairam Mandal, and Jarjious Shaikh serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231DL2000PLC106926
- Company No.
106926
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Jul 2000
- Date of AGM
15 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Tetris Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhajit Sinha  | Director | 15-Sep-2010 | Current |
| Jairam Mandal | Director | 01-Jan-2019 | Current |
| Jarjious Shaikh | Director | 22-Feb-2010 | Current |
Financial Performance of Tetris Biotech.
Tetris Biotech Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 4134.52% increase. The company also saw a substantial improvement in profitability, with a 75% increase in profit. The company's net worth dipped by a decrease of 4.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tetris Biotech?
In 2018, Tetris Biotech had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Khushi Tie-Up LlpSubhajit Sinha is a mutual person
- Swanlake Vyapaar Llp
Subhajit Sinha is a mutual person
- Fastflow Vinimay Llp
Subhajit Sinha is a mutual person
- Evershine Barter Llp
Subhajit Sinha is a mutual person
- Mandar Developers Llp
Subhajit Sinha is a mutual person
- Punit Developers Llp
Subhajit Sinha is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tetris Biotech?
Unlock and access historical data on people associated with Tetris Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tetris Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tetris Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
